Publication | Open Access
Prospective evaluation of the tolerability and efficacy of niraparib dosing based on baseline body weight and platelet count: Results from the PRIMA/ENGOT‐OV26/GOG‐3012 trial
20
Citations
7
References
2023
Year
In PRIMA, similar dose intensity, similar efficacy, and improved safety were observed with the ISD compared with the FSD regimen.
| Year | Citations | |
|---|---|---|
Page 1
Page 1